First Enbrel Biosimilar Recommended for Approval in EuropeFirst Enbrel Biosimilar Recommended for Approval in Europe

The EMA has recommended Benepali, an etanercept biosimilar for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news